Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add more filters










Database
Language
Publication year range
1.
J Pharm Sci ; 112(8): 2203-2211, 2023 08.
Article in English | MEDLINE | ID: mdl-37244516

ABSTRACT

Prefilled syringes (PFS) as a primary container for parenteral drug products offer significant advantages, such as fast delivery time, ease of self-administration and fewer dosing errors. Despite the benefits that PFS can provide to patients, the silicone oil pre-coated on the glass barrels has shown migration into the drug product, which can impact particle formation and syringe functionality. Health authorities have urged product developers to better understand the susceptibility of drug products to particle formation in PFS due to silicone oil. In the market, there are multiple syringe sources provided by various PFS suppliers. Due to current supply chain shortages and procurement preferences for commercial products, the PFS source may change in the middle of development. Additionally, health authorities require establishing source duality. Therefore, it is crucial to understand how different syringe sources and formulation compositions impact the drug product quality. Here, several design of experiments (DOE) are executed that focus on the risk of silicone oil migration induced by syringe sources, surfactants, protein types, stress, etc. We utilized Resonant Mass Measurement (RMM) and Micro Flow Imaging (MFI) to characterize silicone oil and proteinaceous particle distribution in both micron and submicron size ranges, as well as ICP-MS to quantify silicon content. The protein aggregation and PFS functionality were also monitored in the stability study. The results show that silicone oil migration is impacted more by syringe source, siliconization process and surfactant (type & concentration). The break loose force and extrusion force across all syringe sources increase significantly as protein concentration and storage temperature increase. Protein stability is found to be impacted by its molecular properties and is less impacted by the presence of silicone oil, which is the same inference drawn in other literatures. A detailed evaluation described in this paper enables a thorough and optimal selection of primary container closure and de-risks the impact of silicone oil on drug product stability.


Subject(s)
Biological Products , Silicone Oils , Humans , Syringes , Pharmaceutical Preparations , Proteins
2.
MAbs ; 15(1): 2199466, 2023.
Article in English | MEDLINE | ID: mdl-37032437

ABSTRACT

Transition metals can be introduced in therapeutic protein drugs at various steps of the manufacturing process (e.g. manufacturing raw materials, formulation, storage), and can cause a variety of modifications on the protein. These modifications can potentially influence the efficacy, safety, and stability of the therapeutic protein, especially if critical quality attributes (CQAs) are affected. Therefore, it is meaningful to understand the interactions between proteins and metals that can occur during the manufacturing process, formulation, and storage of biotherapeutics. Here, we describe a novel strategy to differentiate between ultra-trace levels of transition metals (cobalt, chromium, copper, iron, and nickel) interacting with therapeutic proteins and free metal in solution in the drug formulation using size exclusion chromatography coupled to inductively coupled plasma mass spectrometry (SEC-ICP-MS). Two monoclonal antibodies (mAbs) were coformulated and stored up to nine days in a scaled down model to mimic metal exposure from manufacturing tanks. The samples containing the mAbs were first analyzed by ICP-MS for bulk metal analysis, then studied using SEC-ICP-MS to measure the extent of metal-protein interactions. The SEC separation was used to differentiate metal associated with the mAbs from free metal in solution. Relative quantitation of metal-protein interaction was then calculated using the relative peak areas of protein-associated metal to free metal in solution and weighting it to the total metal concentration in the mixture as measured by bulk metal analysis by ICP-MS. The SEC-ICP-MS method offers an informative means of measuring metal-protein interactions during drug development.


Subject(s)
Antibodies, Monoclonal , Metals , Mass Spectrometry/methods , Metals/analysis , Copper/analysis , Copper/metabolism , Iron
3.
Anal Chim Acta ; 961: 33-41, 2017 Apr 08.
Article in English | MEDLINE | ID: mdl-28224906

ABSTRACT

The recent commercialisation of inductively coupled plasma tandem mass spectrometric (ICP-MS/MS) instruments has provided analytical chemists with a new tool to properly quantify atomic composition in a variety of matrices with minimal sample preparation. In this article, we report on our assessment of the compatibility of 3 sample preparation techniques (open-vessel acid digestion, microwave digestion and alkaline fusion) for the quantification of rare earth elements (REEs) in mineral matrices. The combination of the high digestion temperatures (1050 °C) and using LiBO2 as a flux was the most effective strategy for the digestion of all rare earth elements in mineral matrices and was compatible with ICP-MS/MS measurements. We also assessed the analytical performances of ICP-MS/MS against other plasma-based instrumentation (microwave induced plasma and inductively coupled plasma atomic emission spectroscopy (MIP-AES and ICP-AES, respectively) and single quadrupole inductively coupled plasma mass spectrometry (ICP-MS). The comparative study showed that the concentrations obtained by ICP-MS/MS are in excellent agreement with the certified reference material values, and much more suited than the other analytical techniques tested for the quantification of REEs, which exhibited low detectability and/or spectral interferences for some elements/isotopes. Finally, the ruggedness of the analytical protocol proposed which combines a rapid sample dissolution step performed by an automated fusion unit and an ICP-MS/MS as a detector was established using various certified mineral matrices containing variable levels of REEs.

4.
Anal Chem ; 85(21): 10549-55, 2013 Nov 05.
Article in English | MEDLINE | ID: mdl-24074397

ABSTRACT

A new cloud point extraction procedure has been developed for the quantification of plutonium(IV) in environmental samples. The separation procedure can be either coupled to inductively coupled plasma mass spectrometry (ICPMS) or α spectrometry for plutonium quantification. The method uses a combination of selective ligand (P,P'-di(2-ethylhexyl) methanediphosphonic acid (H2DEH[MDP])) and micelle shielding by bromine formation to enable quantitative extraction of Pu in highly acidic solutions. Cross-optimization of all parameters (nonionic and ionic surfactant, chelating agent, bromate, bromide, and pH) led to optimal of the extraction conditions. Figures of merit of the method for the detection using α spectrometry and ICPMS are reported (limit of detection, limit of quantification, minimal detectable activity, and recovery). Quantitative extractions (>95%) were obtained for a wide variety of aqueous and digested samples (synthetic urine, wastewater, drinking water, seawater, and soil samples). The method features the first successful coupling between α spectrometry and cloud point extraction and is the first demonstration of CPE suitability with metaborate fusion as a sample preparation approach, techniques used extensively in nuclear industries.

5.
Talanta ; 107: 284-91, 2013 Mar 30.
Article in English | MEDLINE | ID: mdl-23598224

ABSTRACT

A procedure has been developed for the cloud point extraction (CPE) of uranium (VI) using H2DEH[MDP] (P,P-di(2-ethylhexyl) methanediphosphonic acid) with inductively coupled plasma coupled to mass spectrometry (ICP-MS). The method is based on the modification of the cloud point temperature using cetyl trimethyl ammonium bromide (CTAB) and KI. Optimal conditions of extraction were found using a cross-optimization of every parameter (non-ionic and ionic surfactant concentrations, chelating agent concentration, pH and the extraction, and phase separation temperatures). Furthermore, the figures of merit of the methodology were assessed (limit of detection, limit of quantification, recovery, sensibility, and linear range) and are reported. Quantitative extraction (99 ± 0.5%) was obtained in drinking water samples over a wide range of uranium concentrations. The approach was also validated using drinking (SCP EP-L-3 and SCP EP-H-3), and wastewater (SCP EU-L-3) certified materials. Interferences from most critical anions and cations were evaluated to determine the reliability of the method. The proposed method showed robustness since its performance is maintained over a wide range of pH and metal ion concentrations.


Subject(s)
Chemical Fractionation/methods , Diphosphonates/chemistry , Polyethylene Glycols/chemistry , Surface-Active Agents/chemistry , Uranium/isolation & purification , Water Pollutants, Radioactive/isolation & purification , Cetrimonium , Cetrimonium Compounds/chemistry , Chelating Agents/chemistry , Chemical Precipitation , Drinking Water/analysis , Limit of Detection , Mass Spectrometry/methods , Micelles , Octoxynol , Wastewater/analysis
SELECTION OF CITATIONS
SEARCH DETAIL
...